Neomed Labs Pacific Biomarkers PAIRimmune are now Nexelis
 
News, Events & Publications × clear filter

or filter by:

subscribe now

Press Release

Nexelis to Acquire Specialty Immunogenicity and Immune-Oncology Testing Laboratory ImmunXperts

March 4, 2020 | Press Release

Laval, Quebec, and Gosselies, Belgium, March 04, 2020 – Nexelis, a portfolio company of Ampersand Capital Partners, and a leading […]

read more

Announcing Nexelis, a new name with long experience in the world of immuno-science.

September 23, 2019 | Press Release

Laval, QC, and Seattle, WA, September 23, 2019 - Today, our merged affiliates, NEOMED-LABS, Pacific Biomarkers and PAIRimmune, are proud […]

read more

NEOMED-LABS and Public Health England Announce a Strategic Agreement

June 27, 2019 | Press Release

Laval, Quebec and Porton, United Kingdom, June 27 2019 – NEOMED-LABS and Public Health England’s (PHE) National Infection Service are […]

read more

NEOMED-LABS / Pacific Biomarkers Strengthens its Immunology Franchise by Acquiring PAIRimmune

June 6, 2019 | Press Release

LAVAL, QC, June 6, 2019 – The recently merged NEOMED-LABS / Pacific Biomarkers (NLPBI), a leading immunology centric service provider specialized […]

read more

Timothy McGrath Appointed Chief Operating Officer of Newly Merged NEOMED-LABS / Pacific Biomarkers

March 28, 2019 | Press Release

LAVAL, QC, and SEATTLE, WA, March 28, 2019 – The newly merged NEOMED-LABS / Pacific Biomarkers, an immunology centric service […]

read more

1 2

back to top
contact us now

contact us

  • This field is for validation purposes and should be left unchanged.